Login

Diversey IPO Preview with CEO Phil Wieland | Phil Wieland - CEO of Diversey Holdings 00:10:00

Share On Facebook Share On Twitter

Phil Wieland is the CEO of Diversey Holdings

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Commodities Unleashed: Insights with Rick Rule of Sprott US Holdings | Legendary Investor and Market Strategist
00:10:00
A Day in the Life of Thomas Moore | Thomas Moore - Fund Manager, abrdn Equity Income Trust
00:10:00
Triumph Gold Corp: Yukon-Based Gold and Copper Exploration and Development Company
00:10:00
Neurosciences Avidity - Myotonic Dystrophy | SARAH BOYCE, PRESIDENT & CHIEF EXECUTIVE, FICER OF AVIDITY BIOSCIENCES INC
00:10:00
Launching a Rolling Fund, Finding Investments|Andrew Gluck,General Partner,irrvrntVC
00:10:00
Interview with Mike on the Transformative Potential of Hydrogen Projects: Insights Ahead of the World Hydrogen Congress North America 2023
00:10:00
Candente Copper Presentation Highlights
00:10:00
Latvian Gas Market: Competitors, Prices, and Future Plans Discussed | Aigars Kalvītis, CEO, AS Latvijas Gaze.
00:00:00
Telix Pharmaceuticals Limited (ASX:TLX) - Christian Behrenbruch, CEO, Telix Pharmaceuticals Ltd
00:10:00
The Distinguished Leaders Lecture Series features Scott Salmirs, President & CEO of ABM Industries, and Eric Mendelson discussing the history and leadership of ABM Industries.|Scott Salmirs, CEO of ABM
00:00:00
ReNeuron Group's phase IIb stroke trial kicks off with first patient treated - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:10:00
Danimer Scientific CEO Talks SPAC Merger and Biodegradable Plastic on 'Squawk Box | Stephen E. Croskrey - CEO of Danimer Scientific

© 2017 - Neuhu+